ZENIQUIN DIN 02241412
Health Canada record
| Active ingredient(s) | MARBOFLOXACIN 200 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Jan-2000 |
| Current status date | 14-Feb-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MARBOFLOXACIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02353970 | AURIZON | VETOQUINOL N A INC | Suspension | MARBOFLOXACIN 3 MG; CLOTRIMAZOLE 10 MG; DEXAMETHASONE (DEXAMETHASONE ACETATE) 0.9 MG | Marketed |
| 02474441 | FORCYL | VETOQUINOL N A INC | Solution | MARBOFLOXACIN 160 MG | Marketed |
| 02241414 | ZENIQUIN | ZOETIS CANADA INC | Tablet | MARBOFLOXACIN 50 MG | Marketed |
| 02241415 | ZENIQUIN | ZOETIS CANADA INC | Tablet | MARBOFLOXACIN 25 MG | Marketed |
| 02241413 | ZENIQUIN | ZOETIS CANADA INC | Tablet | MARBOFLOXACIN 100 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15249 | 2014-02-13 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 6113 | 2002-04-23 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6611 | 1999-12-30 | New Drug Submission (NDS) |
International API supply for MARBOFLOXACIN
2 active FDA Drug Master Files.
Request a quote for ZENIQUIN